Compare AbbVie Inc (ABBV) vs iShares Global Clean Energy ETF (ICLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs iShares Global Clean Energy ETF — how do they compare? AbbVie Inc trades at $252.67 (market cap $449.91B), while iShares Global Clean Energy ETF trades at $19.07. The key difference: AbbVie Inc pays a 2.72% dividend while iShares Global Clean Energy ETF pays none, and AbbVie Inc is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| ABBV | ICLN | |
|---|---|---|
Market Cap | $449.91B | — |
Sector | Health | — |
52-Week High | $261.07 | $23.75 |
52-Week Low | $184.85 | $13.37 |
Enterprise Value | $513.38B | — |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $252.61, down 0.84% on the day, with a bullish technical outlook supported by moving averages and strong support at $248. The company reported revenue of $61.16B in 2025, with EPS beats in recent quarters, though net income margin has trended down to 5.79%. Key growth drivers Skyrizi and Rinvoq are offsetting Humira declines, with positive clinical updates like the Phase 2 ELAHERE data at SGO 2026.
The stock offers a compelling buy case with a consensus price target of $266.33 (5.4% upside) and strong analyst support (68% buy ratings). However, risks include patent cliffs in the 2030s, high debt levels, and margin pressure. Dividend growth is recovering, supporting income investors, but execution on pipeline assets remains critical for sustained expansion.
ICLN, the iShares Global Clean Energy ETF, trades at $19.33, down 1.73% on the day amid a bearish technical signal, with moving averages indicating selling pressure. The fund has gained over 25% year-to-date in 2026, driven by global energy security concerns and investment in renewables, though recent U.S. permit delays and geopolitical tensions pose headwinds. A dividend of $0.06 is scheduled for June 2026.
Outlook remains mixed: strong structural trends support clean energy demand, but policy uncertainty and valuation concerns after recent gains present risks. The ETF offers diversified exposure to global renewables growth, yet investors face volatility from regulatory shifts and competition from other energy sectors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →
